NEWRON PHARMACEUT. EO-20 (NP5) — Free Cash Flow Generation Index

Latest as of June 2025: 0.99x

NEWRON PHARMACEUT. EO-20 (NP5) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of €33.32 Million represents 1% of operating cash flow (€33.60 Million). See NEWRON PHARMACEUT. EO-20 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.99x

Free Cash Flow / Operating CF

Free Cash Flow

€33.32 Million

EUR

Operating Cash Flow

€33.60 Million

EUR

Capital Expenditures

€31.00K

EUR

NEWRON PHARMACEUT. EO-20 Free Cash Flow Generation Index (2012–2012)

Historical FCF Generation Index trend for NEWRON PHARMACEUT. EO-20 across 1 annual periods. Explore NEWRON PHARMACEUT. EO-20 debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for NEWRON PHARMACEUT. EO-20 (2012–2012)

Year-by-year Free Cash Flow Generation Index for NEWRON PHARMACEUT. EO-20. For the full company profile including market capitalisation, see NP5 market cap overview.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2012	1.00x	€5.81 Million	€5.83 Million	€11.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).